Diabetes has emerged as a major health problem worldwide, with serious health-related and socioeconomic impacts on individuals and populations. Furthermore, the pandemic growth of diabetes is being spurred on by transitioning demographics (e.g. population aging), socioeconomic, migratory, nutritional, and lifestyle patterns, and an affiliated proliferation of overweight and obese adults and children. The International Diabetes Federation estimated 285 million people with diabetes worldwide in 2010 [3], and projects that the absolute number will surpass 400 million in the coming 20 years. The overwhelming majority of this escalation is attributable to the increase in the incidence of type 2 diabetes mellitus (T2DM). Rapid socioeconomic transformations seen with globalization, increasing urbanization, industrialization, and marketization of developing regions will also result in a parallel growth of diabetes precursors (impaired fasting glucose. [IFG], and impaired glucose tolerance [IGT]), resulting in health consequences. Contemporary estimates endorse that two-thirds of those with diabetes live in low- and center-earnings countries (LMIC). This challenges conventional paradigms that segregate continual non-communicable sicknesses (NCDs) as issues of affluent nations. Eight of the top 10 nations with the highest absolute numbers of people with diabetes are developing or transitioning economic system countries. Even as this burden of greater absolute numbers can be partially defined via the larger population length, the costs at which NCDs are increasing in those nations amid transition are a great deal steeper when compared with the ones in more developed affluent nations; By using 2025, the number of diabetes instances will increase by using 170% in low and center-profit nations, as compared to a 41% growth in evolved nations. Thus far, the attention on health burdens in the developing world has focused justifiably on the persistence of infectious diseases and nutritional deficiencies; however, these same countries must also contend with 80% of global mortality associated with chronic diseases.